Financhill
Back

AtriCure Vs. Perspective Therapeutics Industry Stock Comparison

Sell
34

ATRC
AtriCure

Last Price:
42.26
Seasonality Move:
10.94%
Sell
25

CATX
Perspective Therapeutics

Last Price:
0.27
Seasonality Move:
-9.02%
Sell
34
AtriCure (ATRC) is a Sell

Is AtriCure a Buy, Sell or Hold?

  • The current AtriCure [ATRC] share price is $43.33. The Score for ATRC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $0.27. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRC Stock Price Chart

What is AtriCure's stock price today?

  • The AtriCure share price today is $43.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $0.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.

ATRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 43.91 Sell
Chaikin Money Flow: 219236 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.25 - 45.29) Sell
Bollinger Bands (100): (44.56 - 52.42) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 35.34 Sell
Chaikin Money Flow: -3321 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.28 - 0.4) Sell
Bollinger Bands (100): (0.38 - 0.64) Sell

ATRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.61 Buy
20-day SMA: 43.22 Buy
50-day SMA: 47.9 Sell
200-day SMA: 45.34 Sell
8-day EMA: 43.11 Buy
20-day EMA: 43.76 Sell
50-day EMA: 46.01 Sell
200-day EMA: 46.65 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.28 Sell
20-day SMA: 0.32 Sell
50-day SMA: 0.42 Sell
200-day SMA: 0.48 Sell
8-day EMA: 0.28 Sell
20-day EMA: 0.32 Sell
50-day EMA: 0.4 Sell
200-day EMA: 0.47 Sell

AtriCure Earnings Growth & ATRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.08 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

AtriCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):